What's The Future of Cancer Immunotherapy? World Renowned Cancer Expert Shares His Perspective

curncman
Posts: 1264
Joined: Fri Jun 26, 2020 8:27 am

Parallel CAR T-Cell Immunotherapy of Solid Tumours by John Maher

Post by curncman »

Parallel CAR T-Cell Immunotherapy of Solid Tumours by John Maher


curncman
Posts: 1264
Joined: Fri Jun 26, 2020 8:27 am

World CRISPR Day 2021 - Session 1 - Cell & Gene Therapy

Post by curncman »

World CRISPR Day 2021 - Session 1 - Cell & Gene Therapy


curncman
Posts: 1264
Joined: Fri Jun 26, 2020 8:27 am

CAR-Ts, NKs, Gene editing: Past, Present and Future of Cell Therapies for Immuno-Oncology

Post by curncman »

CAR-Ts, NKs, Gene editing: Past, Present and Future of Cell Therapies for Immuno-Oncology
Justin Eyquem is quite a unique witness of the emergence of CAR-T cell therapies. He did his PhD in partnership with CAR-T company Cellectis. In 2014, he joined the lab of Michel Sadelain at the MSKCC, who co-founded Juno Therapeutics and is now involved with leading CAR-T cell companies such as Fate Therapeutics and Atara Biotherapeutics. Justin eventually established his own lab at USCF and co-founded Mnemo Therapeutics with Michel Sadelain in 2018. In this episode, we talk about his experience, lessons learned from the first wave of CAR-T cell therapies, as well as the future of the field (NKs, allogeneic strategies, multiplexed gene editing, combinatorial approaches, and more). A great episode !


Post Reply